Showing 1 - 2 results of 2 for search 'Mika Kontro', query time: 0.01s Refine Results
  1. 1
    CLEVER-1 targeting antibody, bexmarilimab, supports HLA-DR expression and alters ex vivo responsiveness to azacitidine and venetoclax in myeloid malignancies

    CLEVER-1 targeting antibody, bexmarilimab, supports HLA-DR expression and alters ex vivo responsiveness to azacitidine and venetoclax in myeloid malignancies by Sofia Aakko, Arno Ylitalo, Heikki Kuusanmäki, Jenna H. Rannikko, Mari Björkman, Jami Mandelin, Caroline A. Heckman, Mika Kontro, Maija Hollmén

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Venetoclax triggers sublethal apoptotic signaling in venetoclax-resistant acute myeloid leukemia cells and induces vulnerability to PARP inhibition and azacitidine

    Venetoclax triggers sublethal apoptotic signaling in venetoclax-resistant acute myeloid leukemia cells and induces vulnerability to PARP inhibition and azacitidine by Mahesh Tambe, Sarah Unterberger, Mette C. Kriegbaum, Ida Vänttinen, Ezgi June Olgac, Markus Vähä-Koskela, Mika Kontro, Krister Wennerberg, Caroline A. Heckman

    Published 2024-10-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: